Agenus Inc. Common Stock is a pharmaceutical company that specializes in the development of innovative cancer immunotherapies and vaccines. With a robust pipeline of potential therapeutics, Agenus Inc. is committed to transforming the way cancer is treated and improving patient outcomes.
